Abstract:Hepatitis C represents a serious health issue. Approximately 185 million people are infected with the virus and 350,000 people die every year as a consequence of this disease. New direct-acting antiviral agents achieve viral eradication in more that 90 % of the treated patients. More importantly, patients with advanced liver disease or those nonresponders to a previous course of treatment with an interferon-based therapy will also have the chance of curing hepatitis C (HCV) infection with these new drugs. In c… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.